| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/22/2006 | US20060135504 N-(substituted arylmethyl)-4-(disubstituted methyl) piperidines and pyridines |
| 06/22/2006 | US20060135503 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents; N-[2-[[(cis) -2-[[1- (4-Chlorophenyl)ethyl]amino]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide |
| 06/22/2006 | US20060135502 Cyclic derivatives as modulators of chemokine receptor activity |
| 06/22/2006 | US20060135501 Piperidinyl-thiazole carboxylic acid derivatives as angiogenesis inhibitors |
| 06/22/2006 | US20060135500 Novel oral pharmaceutical suspension of cefdinir crystal |
| 06/22/2006 | US20060135499 Method of achieving accelerated weight loss by administration of a weight loss accelerating agent to a dieting mammal |
| 06/22/2006 | US20060135498 yeast or fungal acitvity inhibiting using a composition comprising polyphyllin D ; for oral microbial infections, including periodontal disease and dental caries; (3 beta ,25R)-spirost-5-en-3-yl O- alpha -L-arabinofuranosyl-(1 --> 4)-O-[6-deoxy- alpha -L-mannopyranosyl-(1 --> 2)]- beta -D-glucopyranoside |
| 06/22/2006 | US20060135497 Therapy for a patient in need of treatment for congestive heart failure, hypertension, or chronic kidney disease comprising co-administering a therapeutically effective dose of metolazone and eplerenone |
| 06/22/2006 | US20060135496 Methods of hormonal treatment utilizing ascending-dose extended cycle regimens |
| 06/22/2006 | US20060135495 multiple modes of activity; compounds useful for the treatment of strains of HIV that are resistant to treatment with other known compounds like DSB and RPR103611; cyclopenta[a]chrysene derivatives 3a-substituted with a carboxyalkylcarbamoyl group and 9-substituted with a carboxyalkylcarbonyloxy group |
| 06/22/2006 | US20060135494 Methods of treating injuries of the nervous system associated with hemorrhage |
| 06/22/2006 | US20060135493 Use of 2-methylene-19-nor-20(S)-1alpha,25-dihydroxyvitamin D3 to increase bone strength |
| 06/22/2006 | US20060135492 Use of 2-methylene-19-nor-20(S)-1alpha,25-dihydroxyvitamin D3 to increase bone strength |
| 06/22/2006 | US20060135491 Vitamin D3 analog useful for the treatment of osteoporosis |
| 06/22/2006 | US20060135490 Targeting mPGES-1 as a treatment for inflammation which avoids cardiovascular risk |
| 06/22/2006 | US20060135489 Chemical compounds containing tocopherol and at least one additional pharmaceutical active substrate |
| 06/22/2006 | US20060135488 protein tyrosine phosphatase 1B (PTP1B) modulators; type 2 diabetes, obesity; increasing insulin sensitivity; 1-Carboxymethoxy-3,8-dithia-cyclopenta[a]indene-2-carboxylic acid |
| 06/22/2006 | US20060135487 Piperazine derivatives and their use as anti-inflammatory agents |
| 06/22/2006 | US20060135486 Use of sulfonamide-including compounds in combination with angiogenesis inhibitors |
| 06/22/2006 | US20060135484 Vesicant treatment with phenyl-thiophene type vitamin d receptor modulators |
| 06/22/2006 | US20060135483 Oxygen/nitrogen heterocycle inhibitors of tyrosine phosphatases |
| 06/22/2006 | US20060135482 Use of fosinopril to reduce cardiovascular events in disalysis patients |
| 06/22/2006 | US20060135481 water soluble; anticancer agents; Pyridinium Narcistatin |
| 06/22/2006 | US20060135480 Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of phex |
| 06/22/2006 | US20060135479 Phosphono-carboxylate compounds for treating amyloidosis |
| 06/22/2006 | US20060135478 Boronated metal-phthalocyanines, process for their preparation, pharmaceutical compositions comprising them and use thereof |
| 06/22/2006 | US20060135477 Compositions for injectable ophthalmic lenses |
| 06/22/2006 | US20060135476 A drug delivery stent or synthetic graft coated with a controlled release matrix and one or more drug for balloon angioplasty procedures |
| 06/22/2006 | US20060135475 Process for preparing an alpha-lipoic acid/cyclodextrin complex and product prepared |
| 06/22/2006 | US20060135474 Methods for the preparation, isolation and purification of epothilone B, and X-ray crystal structures of epothilone B |
| 06/22/2006 | US20060135473 Lyophilization or freeze drying the piroxicam:beta-cyclodextrin inclusion compound by dissolving and heating the two components in an aqueous solution of of ammonium hydroxide; freeze drying; vacuum drying; water soluble amorphous product with high bioavailability; industrial scale |
| 06/22/2006 | US20060135472 Use of water-soluble polymers to improve stability of diiodomethyl-para-tolylsulfone in complex matrices |
| 06/22/2006 | US20060135471 Anti-obesity compositions |
| 06/22/2006 | US20060135470 Bone disorders; antiinflammatory agents; antiarthritic agents; mixture of chondroitin sulfate, n-acetylglucosamine and hyaluronic acid |
| 06/22/2006 | US20060135469 Separate type medical material |
| 06/22/2006 | US20060135468 Treatment of refractory cancers using NA+/K+ ATPase inhibitors |
| 06/22/2006 | US20060135467 Partial and full agonists of A1 adenosine receptors |
| 06/22/2006 | US20060135466 Activating a guanosine compound followed by hydrolysis; alkylating the hydrolyzed compound with subsequent amination; synthesis of 2-(2-(4-chlorophenyl) ethoxy)adenosine |
| 06/22/2006 | US20060135465 N6-Hydroxy-9H-(2'- beta -C-methyl- beta -D-ribofuranosyl)purine ; prepared from a precursor with an electrophilic center that is reacted with a dual nucleophilic reagent under conditions such that the reaction product is formed with high stereoselectivity |
| 06/22/2006 | US20060135464 Anti-infective compositions, methods and systems for treating pathogen-induced disordered tissues |
| 06/22/2006 | US20060135463 Methods and compositions for the treatment of lupus using clofarabine |
| 06/22/2006 | US20060135461 Using survivin inhibitor |
| 06/22/2006 | US20060135460 Methods, assays and compositions for treating retinol-related diseases |
| 06/22/2006 | US20060135458 For use as therapeutic agents in viral infections by human and animal viruses and in cancers caused by oncogene viruses |
| 06/22/2006 | US20060135456 Methods and compositions for RNA interference |
| 06/22/2006 | US20060135454 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 06/22/2006 | US20060135453 Down-regulation of target-gene with pei/single-stranded oligoribonucleotide complexes |
| 06/22/2006 | US20060135449 A NF- kappa B decoy oligodeoxynucleotide of the sequence GGATTTCCC delivered in a liposome through the carotid artery; antiischemic agents, antitumor agents; analgesics, Alzheimer's Disease; gene transfection |
| 06/22/2006 | US20060135448 Hydroxypyridinones for the local treatment of skin microcirculatroy disorders |
| 06/22/2006 | US20060135447 Azetidinyl derivatives of descladinosylerythromycin A; e.g., 3-descladinosyl-11,12-dideoxy-6-O-methyl-3-oxo-12,11-(oxycarbonyl-(1-(1R-(1,8-naphthyridin-4-yl)-ethyl)-azetidin-3-yl)-imino)-erythromycin A; clarithromycin resistant S. pyogenes and S. pneumo; 1-[1,8]naphthyridin-4-yl-ethanol or -ethanone |
| 06/22/2006 | US20060135446 Composition for improving blood fluidity |
| 06/22/2006 | US20060135445 Breast cancer-resistant protein inhibitor |
| 06/22/2006 | US20060135444 Combination of flavonoid and procyanidin for the reduction of the mammalian appetite |
| 06/22/2006 | US20060135443 Use of Na*/K*-ATPase inhibitors and antagonists thereof |
| 06/22/2006 | US20060135442 Pancreatic cancer treatment using Na+/K+ ATPase inhibitors |
| 06/22/2006 | US20060135441 Combinatorial chemotherapy treatment using Na+/K+ ATPase inhibitors |
| 06/22/2006 | US20060135440 Use of ribose to alleviate rhabdomyolysis and the side effects of statin drugs |
| 06/22/2006 | US20060135439 Hyaluronic acid tetrasaccharide; hyaluronic acid; glucuronic acid, N-acetylglucosamine; spinal cord injury or nerve trauma |
| 06/22/2006 | US20060135437 Novel use of peptide compounds for treating pain in trigeminal neuralgia |
| 06/22/2006 | US20060135435 Agent that retards transformation of hormone-dependent cancer to non-hormone-dependent cancer |
| 06/22/2006 | US20060135417 Use of the crh (corticotropin releasing hormone)-ucn (urocortin) system in the treatment of inflammatory diseases |
| 06/22/2006 | US20060135415 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 06/22/2006 | US20060135406 Compositions and methods for treating pathologies that necessitate suppression of gastric acid secretion |
| 06/22/2006 | US20060135404 polymer conjugated drug with polylactams; antitumor, anticancer agents for prostate cancer, breast cancer, ovarian cancer, colon cancer, leukemia, and lung cancer; rheumatic diseases; autoimmune diseases |
| 06/22/2006 | US20060135403 Therapeutic formulations for the treatment of beta-amyloid related diseases |
| 06/22/2006 | US20060135402 in combination with oral delivery agent such as N-(5-chlorosalicyloyl)8-aminocaprylic acid (5-CNAC), N-10-[2-hydroxybenzoyl]aminodecanoic acid (SNAD) or N-(8-[2-hydroxybenzoyl]amino)caprylic acid (SNAC), or their disodium salts to improve bioavailability |
| 06/22/2006 | US20060134791 Masked targeted expression cassette which expresses a gene product only in the presence of target molecule; neoplasm |
| 06/22/2006 | US20060134782 Differentiated cells suitable for human therapy |
| 06/22/2006 | US20060134767 Mitotic kinesin binding site |
| 06/22/2006 | US20060134764 Gene cluster involved in safracin biosynthesis and its uses for genetic engineering |
| 06/22/2006 | US20060134759 Isolation of glucan particles and uses thereof |
| 06/22/2006 | US20060134724 Method and probe for identifying bacterial virulence modifying agents, agents thus identifed, and their use |
| 06/22/2006 | US20060134715 Optically detectable organophosphonates |
| 06/22/2006 | US20060134668 Methods for treating patients and identifying therapeutics |
| 06/22/2006 | US20060134632 Oligonucleotides and methods for detecting hepatitis C viral nucleic acids |
| 06/22/2006 | US20060134595 Polymer affinity matrix, a method for the production and use thereof |
| 06/22/2006 | US20060134286 Gallocatechin gallate-containing composition |
| 06/22/2006 | US20060134249 proanthocyanidin from hops; detoxification a toxicity from germs causing infectious disease |
| 06/22/2006 | US20060134247 With soluble fiber of Musa spp. fruit such as plantains or bananas |
| 06/22/2006 | US20060134244 Breast health supplement and detoxification preparations |
| 06/22/2006 | US20060134242 Synergistic composition for the treatment of diabetes mellitus |
| 06/22/2006 | US20060134239 Agents against microorganisms containing patchouli oil, patchouli alcohol and/or the derivatives thereof |
| 06/22/2006 | US20060134237 For treating fungal and yeast infections |
| 06/22/2006 | US20060134236 Downregulating production of immunoglobulin E; prostaglandins; leukotrienes |
| 06/22/2006 | US20060134235 External preparation for improving blood flow |
| 06/22/2006 | US20060134234 Mixture of xanthine, plant extract containing polyurethane powder and dimethicone; reducing cellulite |
| 06/22/2006 | US20060134233 Nitric oxide and its biomedical significance |
| 06/22/2006 | US20060134232 Herbal supplement for cognitive related impairment due to estrogen loss |
| 06/22/2006 | US20060134228 Medicine for prevention of and treatment for amyloidosis |
| 06/22/2006 | US20060134227 Compositions including iron |
| 06/22/2006 | US20060134226 Compositions useful to treat ocular neovascular diseases and macular degeneration |
| 06/22/2006 | US20060134225 Phosphate binder with reduced pill burden |
| 06/22/2006 | US20060134223 Process for producing microparticles |
| 06/22/2006 | US20060134214 Enteric coated bead comprising epothilone or epothilone analog, and preparation and administration thereof |
| 06/22/2006 | US20060134212 Lercanidipine immediate release compositions |
| 06/22/2006 | US20060134208 Controlled release and taste masking oral pharmaceutical composition |
| 06/22/2006 | US20060134207 Dosage form containing diphenhydramine and another drug |
| 06/22/2006 | US20060134205 Process for preparing a pharmaceutical composition |
| 06/22/2006 | US20060134200 Pharmaceutical composition based on agonist of benzodiazepine |
| 06/22/2006 | US20060134198 Pharmaceutical compositions with improved dissolution |